Literature DB >> 35677493

Impact of curative parathyroidectomy on left ventricular functions assessed with 2D ECHO and MUGA study.

Kishore Abuji1, Divya Dahiya1, Ashwani Sood2, Madan Parmar2, Sanjay Kumar Bhadada3, Rajesh Vijayvergiya4, Arunanshu Behera1.   

Abstract

Objectives: Primary hyperparathyroidism (PHPT) is associated with increased cardiovascular morbidity and mortality with inconsistent results on the reversibility of cardiovascular changes after parathyroidectomy (PTx). The present study was undertaken to evaluate both structural and functional cardiac changes and their reversal after PTx in patients with PHPT. Material and
Methods: Thirty patients of symptomatic PHPT without cardiovascular risk factors were evaluated prospectively by means of 2D echocar- diography (ECHO) and Multigated Acquisition (MUGA) study before surgery and six months after curative parahyroidectomy.
Results: Nine of 30 patients had hypertension which improved in two after PTx (p 0.20). Two patients had left ventricle hypertrophy on 2D ECHO pre- operatively which improved after PTx (p <0.001). Left ventricular ejection fraction (LVEF) did not show significant change before and after PTx on 2D ECHO. Nine out of 30 patients had hypertension which improved in two after PTx (p 0.20). Two patients with left ventricle hypertrophy on 2D ECHO preoperatively improved after PTx (p <0.001). Left ventricular ejection fraction (EF) did not depict significant change before and after PTx on 2D ECHO. Whereas, four out of six patients with preoperative EF <50% representing systolic dysfunction on MUGA study showed improvement after PTx. On 2D ECHO, eight patients depicted diastolic dysfunction which improved in six patients after curative surgery (p= 0.07). However, on MUGA study, 13 pa- tients presented with tTPF >180 ms indicating diastolic dysfunction, of which ten showed improvement after PTx (p= 0.007).
Conclusion: The present study analyzed preoperative and postoperative cardiac function using both 2D ECHO and MUGA study. MUGA study provided a more objective assessment of the cardiac function by determining left ventricular ejection fraction and diastolic dysfunction.
Copyright © 2021, Turkish Surgical Society.

Entities:  

Keywords:  2D ECHO; Muga study; cardiac manifestations; left ventricular dysfunction; parathyroidectomy; primary hyperparathyroidism

Year:  2021        PMID: 35677493      PMCID: PMC9130932          DOI: 10.47717/turkjsurg.2021.5167

Source DB:  PubMed          Journal:  Turk J Surg        ISSN: 2564-6850


  21 in total

1.  Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism.

Authors:  M D Walker; T Rundek; S Homma; M DiTullio; S Iwata; J A Lee; J Choi; R Liu; C Zhang; D J McMahon; R L Sacco; S J Silverberg
Journal:  Eur J Endocrinol       Date:  2012-06-01       Impact factor: 6.664

2.  Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study.

Authors:  K Dalberg; L A Brodin; A Juhlin-Dannfelt; L O Farnebo
Journal:  Eur J Surg       Date:  1996-03

3.  Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism.

Authors:  Anita Persson; Jens Bollerslev; Thord Rosen; Charlotte L Mollerup; Celina Franco; Gunhild A Isaksen; Thor Ueland; Svante Jansson; Kenneth Caidahl
Journal:  Clin Endocrinol (Oxf)       Date:  2011-02       Impact factor: 3.478

4.  Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.

Authors:  Michael W Yeh; Philip H G Ituarte; Hui Cynthia Zhou; Stacie Nishimoto; In-Lu Amy Liu; Avital Harari; Philip I Haigh; Annette L Adams
Journal:  J Clin Endocrinol Metab       Date:  2013-02-15       Impact factor: 5.958

5.  Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis.

Authors:  Jenifer Brown; Ian H de Boer; Cassianne Robinson-Cohen; David S Siscovick; Bryan Kestenbaum; Matthew Allison; Anand Vaidya
Journal:  J Clin Endocrinol Metab       Date:  2014-11-20       Impact factor: 5.958

6.  Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism.

Authors:  Jens Bollerslev; Thord Rosen; Charlotte L Mollerup; Jörgen Nordenström; Marek Baranowski; Celina Franco; Ylva Pernow; Gunhild A Isaksen; Kristin Godang; Thor Ueland; Svante Jansson
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

7.  Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers.

Authors:  C Berger; O Almohareb; L Langsetmo; D A Hanley; C S Kovacs; R G Josse; J D Adachi; J C Prior; T Towheed; K S Davison; S M Kaiser; J P Brown; D Goltzman
Journal:  Clin Endocrinol (Oxf)       Date:  2014-09-01       Impact factor: 3.478

8.  Increased risk of death from primary hyperparathyroidism--an update.

Authors:  G Hedbäck; A Odén
Journal:  Eur J Clin Invest       Date:  1998-04       Impact factor: 4.686

9.  Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism.

Authors:  P D Broulik; A Brouliková; S Adámek; P Libanský; J Tvrdoň; K Broulikova; J Kubinyi
Journal:  Int J Endocrinol       Date:  2011-02-20       Impact factor: 3.257

Review 10.  Echocardiogram changes following parathyroidectomy for primary hyperparathyroidism: A systematic review and meta-analysis.

Authors:  Corliss A E Best; Rohin Krishnan; Monali S Malvankar-Mehta; S Danielle MacNeil
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.